Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis
Autor: | C. Fairchild, Renzo Canetta, David S. Alberts, G. Sartiano, Laurie Smaldone, Marcel Rozencweig, M. Brady, S. E. Schwartz, Patricia M. Plezia, M. Dorn, M. Aapro, C. Comerski |
---|---|
Rok vydání: | 1990 |
Předmět: |
Male
Cancer chemotherapy Metoclopramide Vomiting medicine.medical_treatment Antineoplastic Agents Pharmacology chemistry.chemical_compound Mice 5-HT3 Receptor Antagonist Dogs Neoplasms Medicine Animals Humans Radiology Nuclear Medicine and imaging Chemotherapy business.industry Antagonist Ferrets Hemodynamics General Medicine Middle Aged Rats Oncology chemistry Toxicity Antiemetics Dopamine Antagonists Female Serotonin Antagonists medicine.symptom Cisplatin business Batanopride |
Zdroj: | Cancer treatment reviews. 17(2-3) |
ISSN: | 0305-7372 |
Databáze: | OpenAIRE |
Externí odkaz: |